Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Sabra Health Care REIT Inc
XBER:SBC

Watchlist Manager
Sabra Health Care REIT Inc Logo
Sabra Health Care REIT Inc
XBER:SBC
Watchlist
Price: 17.65 EUR 0.51% Market Closed
Market Cap: €4.1B
Write Note Create Alert Ask AI

Wall St Price Targets

SBC Price Targets Summary
Sabra Health Care REIT Inc

Wall Street analysts forecast SBC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SBC is 19.6 EUR with a low forecast of 16.33 EUR and a high forecast of 22.34 EUR.

SBC Lowest Forecast
Wall Street Target
€16.33
-7% Downside
SBC Average Forecast
Wall Street Target
€19.6
11% Upside
SBC Highest Forecast
Wall Street Target
€22.34
27% Upside
Lowest Forecast
Price Target
16.33 EUR
7% Downside
Average Forecast
Price Target
19.6 EUR
11% Upside
Highest Forecast
Price Target
22.34 EUR
27% Upside
Sabra Health Care REIT Inc Competitors:
Price Targets
M
MAC
MacroAsia Corp
91% Upside
HLIO
Helios Technologies Inc
23% Upside
WERN
Werner Enterprises Inc
13% Upside
DK
Delek US Holdings Inc
-14% Downside
M
MAC
MacroAsia Corp
91% Upside
HLIO
Helios Technologies Inc
23% Upside
WERN
Werner Enterprises Inc
13% Upside
DK
Delek US Holdings Inc
-14% Downside
UE
Urban Edge Properties
16% Upside
WELL
Welltower Inc
11% Upside

Revenue
Forecast

17% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
17% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 12%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Sabra Health Care REIT Inc

Operating Income
Forecast

13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 6 years is 13%.

What are analyst estimates?

Pre-Tax Income
Forecast

17% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
17% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is 13%.

What are analyst estimates?

Net Income
Forecast

17% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 6 years is 14%.

What are analyst estimates?

Continue SBC Research

Summary
SBC intrinsic value, competitors valuation, and company profile.
DCF Valuation
SBC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SBC stock valuation using valuation multiples.
Wall St Estimates
SBC price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SBC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Sabra Health Care REIT Inc listings:
NASDAQ • USD
SBRA
 F • EUR
SBC
 SWB • EUR
SBC
 NASDAQ • USD
SBRAP
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SBC's stock price target?
Price Target
19.6 EUR

According to Wall Street analysts, the average 1-year price target for SBC is 19.6 EUR with a low forecast of 16.33 EUR and a high forecast of 22.34 EUR.

What is the Revenue forecast for Sabra Health Care REIT Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 12%.

What is the Operating Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 6 years is 13%.

What is the Pre-Tax Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is 13%.

What is the Net Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 6 years is 14%.

Back to Top
ALPHA SPREAD
Follow us
Join 355,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett